PharmaCyte Biotech Inc (PMCB)

[saladan2]

J & J has a long way to go if we only consider what it take to get to clinical trials. (human) All share holders should be aware of the world class team working on PMCB. The Doctors, Researchers and prof. biotech executives joined PMCB because the science answered many of the questions involved in encapsulation. Possibly the most important question was satisfied and that was why these people joined so enthusiastically. The ability of CIAB to protect against immune response. Obviously, J & J's efforts have not attained that level of success, as indicated in their release. Add to that the doubts regarding duration of viability and you see J & J as a distant also ran in this arena. PMCB seems to have a better product, more proven, human and lab and inert. J & J is not a threat unless you want to scare investors and make waves. Stay long and GLTA